BrightSpring Soars to All-Time High on Quality Strength: Still a Buy?

Key Takeaways BrightSpring soared 120% year over year, far outperforming AMED, OPCH, and the Medical sector. BTSG posted Q1 revenue and EPS growth of 14% and 111%, respectively, beating estimates on both fronts. BTSG's Home Health now has 80% of branches rated 4 stars or higher, with broad quality gains across services.BrightSpring Health Services (BTSG) reached an all-time high of $25.57 on June 9, marking a meteoric 120% stock surge over the past year and in sharp contrast to the declines across the bro ...